Current therapies and future possibilities for drug development against liver-stage malaria
- PMID: 27249674
- PMCID: PMC4887158
- DOI: 10.1172/JCI82981
Current therapies and future possibilities for drug development against liver-stage malaria
Abstract
Malaria remains a global public health threat, with half of the world's population at risk. Despite numerous efforts in the past decade to develop new antimalarial drugs to surmount increasing resistance to common therapies, challenges remain in the expansion of the current antimalarial arsenal for the elimination of this disease. The requirement of prophylactic and radical cure activities for the next generation of antimalarial drugs demands that new research models be developed to support the investigation of the elusive liver stage of the malaria parasite. In this Review, we revisit current antimalarial therapies and discuss recent advances for in vitro and in vivo malaria research models of the liver stage and their importance in probing parasite biology and the discovery of novel drug candidates.
Figures
Similar articles
-
The Development Process for Discovery and Clinical Advancement of Modern Antimalarials.J Med Chem. 2019 Dec 12;62(23):10526-10562. doi: 10.1021/acs.jmedchem.9b00761. Epub 2019 Aug 20. J Med Chem. 2019. PMID: 31385706 Review.
-
Imaging of Plasmodium liver stages to drive next-generation antimalarial drug discovery.Science. 2011 Dec 9;334(6061):1372-7. doi: 10.1126/science.1211936. Epub 2011 Nov 17. Science. 2011. PMID: 22096101 Free PMC article.
-
Resisting resistance: is there a solution for malaria?Expert Opin Drug Discov. 2016;11(4):395-406. doi: 10.1517/17460441.2016.1154037. Epub 2016 Feb 29. Expert Opin Drug Discov. 2016. PMID: 26926843 Review.
-
Supporting malaria elimination with 21st century antimalarial agent drug discovery.Drug Discov Today. 2015 Oct;20(10):1265-70. doi: 10.1016/j.drudis.2015.06.009. Epub 2015 Jun 21. Drug Discov Today. 2015. PMID: 26103616 Review.
-
The antimalarial activity of indole alkaloids and hybrids.Arch Pharm (Weinheim). 2020 Nov;353(11):e2000131. doi: 10.1002/ardp.202000131. Epub 2020 Aug 12. Arch Pharm (Weinheim). 2020. PMID: 32785974 Review.
Cited by
-
Evaluation of the genotoxicity, cytotoxicity and antimalarial effect of sodium metavanadate po in a Plasmodium yoelii yoelii infected murine model.Toxicol Rep. 2020 Aug 15;7:1001-1007. doi: 10.1016/j.toxrep.2020.08.006. eCollection 2020. Toxicol Rep. 2020. PMID: 32874923 Free PMC article.
-
Toxicological Evaluation and Protective Effects of Ethanolic Leaf Extract of Cassia spectabilis DC on Liver and Kidney Function of Plasmodium berghei-Infected Mice.Vet Med Int. 2022 Feb 15;2022:6770828. doi: 10.1155/2022/6770828. eCollection 2022. Vet Med Int. 2022. PMID: 35211286 Free PMC article.
-
Interactions of primaquine and chloroquine with PEGylated phosphatidylcholine liposomes.Sci Rep. 2021 Jun 14;11(1):12420. doi: 10.1038/s41598-021-91866-0. Sci Rep. 2021. PMID: 34127730 Free PMC article.
-
Chloroquine and Sulfadoxine-Pyrimethamine Resistance in Sub-Saharan Africa-A Review.Front Genet. 2021 Jun 25;12:668574. doi: 10.3389/fgene.2021.668574. eCollection 2021. Front Genet. 2021. PMID: 34249090 Free PMC article. Review.
-
Synthesis and antiplasmodial activity of regioisomers and epimers of second-generation dual acting ivermectin hybrids.Sci Rep. 2022 Jan 12;12(1):564. doi: 10.1038/s41598-021-04532-w. Sci Rep. 2022. PMID: 35022455 Free PMC article.
References
-
- WHO. World Malaria Report 2014. Geneva, Switzerland: World Health Organization; 2014.
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Miscellaneous